ArticleBritish journal of cancer2015

A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium.

S Lheureux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.